Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the randomized phase III KEYNOTE-177 study Meeting Abstract
| Authors: | Shiu, K. K.; AndreĢ, T.; Kim, T. W.; Vittrup Jensen, B.; Jensen, L. H.; Punt, C. J. A.; Smith, D.; Garcia-Carbonero, R.; Alcaide-Garcia, J.; Gibbs, P.; de la Fouchardiere, C.; Rivera, F.; Elez Fernandez, M. E.; Le, D. T.; Yoshino, T.; Zuo, Y.; Fogelman, D.; Adelberg, D. E.; Diaz, L. A. |
| Abstract Title: | Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the randomized phase III KEYNOTE-177 study |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S1271 |
| End Page: | S1272 |
| Language: | English |
| ACCESSION: | WOS:001087480203511 |
| DOI: | 10.1016/j.annonc.2023.10.024 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA32 -- Source: Wos |
